Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Conditions

• Prostate Cancer Aggressiveness

Eligibility Criteria

Sex

MALE

Age

40 Years - 80 Years

Healthy Volunteers

Not accepted

Interventions

• Subtraction Normalized Expression of Phagocytes Blood Test — DIAGNOSTIC_TEST
  Non-invasive blood based immunogenomic assay that targets RNA sequencing to identify disease and disease aggressiveness

Study Details

A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.

Key Dates

Start date

Sep 9, 2019

Status verified

Mar 2026

Primary completion

Nov 15, 2026

Completion

Sep 30, 2029

Study Design

Enrollment

2,000 participants (estimated)

Primary Outcome Measure

Collect performance results on assay's ability to identify occult aggressive disease in active surveillance population. [ Time Frame: 1 year ]

Central Contacts

• Jessica DeHart
  619-316-1416
  [email protected]

Locations (1)

Find similar trials in Royal Oak, MI